Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

301 Press Releases
DateTitleCompany
02 Dec 16 Cerevance Launched with New Technology, Drug Portfolio and $36M in Cash to Tackle Brain Diseases Takeda Pharmaceutical Company Limited,
Published by
Business Wire
30 Nov 16 NINLARO® (ixazomib) Receives Conditional Approval from the European Commission to Treat Relapsed or Refractory Multiple Myeloma Takeda UK
30 Nov 16 Takeda to Invest More Than 100 Million Euros in Dengue Vaccine Manufacturing Plant in Germany Takeda Pharmaceutical Company Limited,
Published by
Business Wire
28 Nov 16 NINLARO™ (ixazomib) Receives Conditional Approval from the European Commission to Treat Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
13 Nov 16 Results of Study of Febuxostat on the Frequency of Acute Gout Flares in Early Gout Takeda Pharmaceuticals U.S.A., Inc.,
Published by
Business Wire
10 Nov 16 Takeda and the New York Academy of Sciences to Honor Commitment to Innovation in Key Areas of Therapeutic Focus Takeda Pharmaceutical Company Limited,
Published by
Business Wire
07 Nov 16 Takeda and Koneksa Health Announce Strategic Collaboration to Use Digital Health Tools in Clinical Trials Takeda Pharmaceutical Company Limited,
Published by
Business Wire
02 Nov 16 Takeda Donates 1 Billion Yen as an Exclusive Partner to the United Nations Foundation for "Global Measles Vaccination for Children" Program Takeda Pharmaceutical Company Limited,
Published by
Business Wire
02 Nov 16 Takeda: CSR Programs Focusing on Maternal and Child Health Takeda Pharmaceutical Company Limited,
Published by
Business Wire
28 Oct 16 Takeda Reports First Half FY2016 Results and Raises Full Year Profit Guidance Takeda Pharmaceutical Company Limited,
Published by
Business Wire
17 Oct 16 Takeda's Vedolizumab Demonstrated Robust Clinical Effectiveness and Safety in Inflammatory Bowel Disease in More Than 50 Real-World Studies Takeda Pharmaceutical Company Limited,
Published by
PR Newswire
10 Oct 16 Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m Takeda Pharmaceutical Company Limited,
Published by
Business Wire
30 Sep 16 Takeda Announces Winners From Its Depression Care Challenge Competition Takeda ,
Published by
PharmiWeb.com
21 Sep 16 Takeda and Affilogic enter into Research Collaboration to Develop Nanofitin®-based Therapies in Central Nervous System Takeda Pharmaceutical Company Limited,
Published by
Business Wire
20 Sep 16 Takeda and Zydus Cadila partner to address the global threat of Chikungunya Takeda Pharmaceutical Company Limited,
Published by
Business Wire
19 Sep 16 Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLAROTM (ixazomib), the First Oral Proteasome Inhibitor, for Use in Patients with Multiple Myeloma Takeda ,
Published by
PharmiWeb.com
16 Sep 16 Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLAROTM (ixazomib), the First Oral Proteasome Inhibitor, for Use in Patients with Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
13 Sep 16 Takeda Supports Global Expansion of the American Cancer Society's Relay For Life (RFL) Takeda ,
Published by
PharmiWeb.com
13 Sep 16 Takeda Supports Global Expansion of the American Cancer Society’s Relay For Life (RFL) Takeda ,
Published by
PharmiWeb.com
27 Aug 16 Takeda Announces Bold, New Access to Medicines Strategy Takeda ,
Published by
PharmiWeb.com
13 Jul 16 IBD Unmasked, a First-of-its-Kind Global Awareness Initiative, Launches to Support and Empower the Inflammatory Bowel Disease Community Takeda Pharmaceutical Company Limited,
Published by
PR Newswire
13 Jul 16 Takeda and the Crohn's & Colitis Foundation of America Partner to Introduce 'IBD Unmasked' A First-of-its-Kind Awareness Campaign Takeda Pharmaceuticals U.S.A., Inc.,
Published by
PR Newswire
31 Aug 16 Takeda Launches Largest Pharmaceutical Company-Sponsored Global Observational Study of Its Kind in Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
05 Jul 16 Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease Takeda Pharmaceutical Company Limited,
Published by
PR Newswire
02 Aug 16 Takeda and TiGenix Announce Publication in The Lancet of 24-Week Results of the Phase 3 ADMIRE-CD Trial Investigating Cx601 in the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease Takeda Pharmaceutical Company Limited,
Published by
PR Newswire
01 Sep 16 Takeda to develop Zika Vaccine with up to $312 million in funding from US Government Takeda Pharmaceutical Company Limited,
Published by
Business Wire
08 Aug 16 Takeda Receives Marketing Authorization in Canada for NINLARO™ (ixazomib) in Relapsed/Refractory Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
29 Jul 16 Takeda Reports 1st Quarter 2016 Results with a Strong Start to the Year and Confidence in Management Guidance Takeda Pharmaceutical Company Limited,
Published by
Business Wire
05 Jul 16 Takeda Submits a New Drug Application for Novel, Oral Proteasome Inhibitor Ixazomib in Japan Takeda Pharmaceutical Company Limited,
Published by
Business Wire
26 Aug 16 Takeda Announces Bold, New Access to Medicines Strategy Takeda Pharmaceutical Company Limited,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.